Mr. John Bencich is an experienced financial executive who has spent over 20 years guiding financial strategy in the life sciences and technology industries. Before his appointment to Chief Executive Officer in 2020, Mr. Bencich served as Achieve Life Sciences Chief Financial and Operating Officer. Prior to joining Achieve Life Sciences in 2017, John served as CFO of OncoGenex Pharmaceuticals, a publicly traded biotechnology company. Before joining OncoGenex in 2014, John served as CFO of Integrated Diagnostics and Allozyne, both private VC-backed companies. Earlier he served as the CFO and Treasurer of Trubion Pharmaceuticals, a publicly traded biotechnology company where he helped complete the successful sale of the company to Emergent BioSolutions. Prior to his role at Trubion, he led the global financial operations for Onyx Software Corporation, a publicly traded software company through its sale to Battery Ventures. John started his career at Ernst & Young LLP. He graduated from the University of San Diego with a BA in Accounting, earned his MBA from Seattle University and was a Certified Public Accountant in the state of Washington for 17 years.